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Jdp2 is an AP-1 family transcription factor that regu-
lates the epigenetic status of histones. Previous
in vitro studies revealed that Jdp2 is involved in os-
teoclastogenesis. However, the roles of Jdp2 in vivo
and its pleiotropic functions are largely unknown.
Here we generated Jdp2–/– mice and discovered
its crucial roles not only in bone metabolism but
also in differentiation of neutrophils. Jdp2–/– mice
exhibited osteopetrosis resulting from impaired os-
teoclastogenesis. Jdp2–/– neutrophils were morpho-
logically normal but had impaired surface expression
of Ly6G, bactericidal function, and apoptosis. We
also found that ATF3 was an inhibitor of neutrophil
differentiation and that Jdp2 directly suppresses
its expression via inhibition of histone acetylation.
Strikingly, Jdp2–/– mice were highly susceptible to
Staphylococcus aureus and Candida albicans infec-
tion. Thus, Jdp2 plays pivotal roles in in vivo bone
homeostasis and host defense by regulating osteo-
clast and neutrophil differentiation.
INTRODUCTION
Jun dimerization protein 2 (Jdp2) is a member of the AP-1 family
and interacts with other AP-1 components, such as c-Jun, JunB,
JunD, and ATF2 (Aronheim et al., 1997). Jdp2 can inhibit the
activation of its binding partners, suggesting that it is a transcrip-
tional repressor (Jin et al., 2001). Furthermore, Jdp2 suppresses
histone acetyltransferase activity and acetylation of reconsti-
tuted nucleosomes, thereby regulating the epigenetic status of
histones (Jin et al., 2006). Extensive studies have revealed
that Jdp2 plays roles in various cellular responses, such as
UV-induced apoptosis and osteoclastogenesis (Huang et al.,
2010).
Osteoclasts are multinucleated cells that degrade bone (Kar-
senty and Wagner, 2002). Bone-forming osteoblasts express1024 Immunity 37, 1024–1036, December 14, 2012 ª2012 Elsevier Inmacrophage colony-stimulating factor (M-CSF) and RANK
ligand (RANKL). When these cytokines stimulate their receptors,
c-fms and RANK, respectively, transcription factors such as
c-Fos, NF-kB, and NFATc1 (Takayanagi, 2007) are activated in
osteoclast precursors and osteoclastogenesis is induced by
stimulation of osteoclastogenic genes, such as tartrate-resistant
acid phosphatase (TRAP) and cathepsin K (CTSK). Jdp2 was
previously implicated in positive regulation of osteoclastogene-
sis via activation of the TRAP and CTSK promoters (Kawaida
et al., 2003). Recent findings indicate that the Jdp2 locus is
hypomethylated and that its transcript is upregulated in common
myeloid precursors and granulocyte-macrophage progenitors
relative to lymphoid lineages (Ji et al., 2010), suggesting that
Jdp2 may also contribute to the differentiation of myeloid cells,
such as neutrophils.
Neutrophils are critical for bacterial clearance. One of the
most impressive morphological features of mature neutrophils
is cytosolic granules, and the mRNA expressions of granule
content genes are significantly higher in immature neutrophils
than in mature neutrophils (Borregaard and Cowland, 1997; Bor-
regaard et al., 2007). There are three different granule subtypes,
i.e., primary, secondary, and tertiary, and the granule proteins
play pivotal roles in bacterial killing. The other bactericidal agents
derived from neutrophils are reactive oxygen species (ROS),
such as superoxide (Forman and Thomas, 1986). Recently, a
novel mechanism of bacterial and fungal killing mediated by
chromatin structures was elucidated, termed the neutrophil
extracellular trap (NET) (Brinkmann et al., 2004). This extracel-
lular structure is released through a cell death requiring ROS
production (Nishinaka et al., 2011) and chromatin decondensa-
tion (Li et al., 2010). Collectively, these findings demonstrate
that neutrophils exert bactericidal activity through several
complex machineries.
Generally, neutrophil subtypes can be distinguished by their
surface markers CD11b and Ly6G. CD11b+Ly6Glo cells are
immature neutrophils with a round nucleus, such as myelocytes,
whereas CD11b+Ly6Ghi cells are band-segmented mature
neutrophils (Hestdal et al., 1991). By using such morphological
and molecular cues, several studies have shown that various
cytokines and transcription factors are critical for properc.
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Figure 1. Jdp2 Expression
(A) qPCR analysis of Jdp2 in splenic T cells (T), B
cells (B), DCs (DC), neutrophils (N), and primary
bone marrow osteoclasts (OC) (n = 3).
(B) qPCR analysis of Jdp2 in MDMs in response to
RANKL stimulation. *p < 0.05 versus 0 hr (n = 3).
(C) MDMs were stimulated with 50 ng/ml RANKL
for 30 hr. Jdp2 levels were analyzed by protein
immunoblotting.
(D) MDMs were transfected with control siRNA
(Cont) or c-Fos-specific siRNA (siFos) and stimu-
lated with 50 ng/ml RANKL for 12 hr. c-Fos and
Jdp2 levels were measured by qPCR (n = 3).
*p < 0.05 versus control siRNA. Error bars, SE.
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Roles of Jdp2 in Osteoclasts and Neutrophilsdevelopment of neutrophils. For example, granulocyte colony-
stimulating factor (G-CSF) plays a pivotal role in proliferation
of neutrophil precursors via activation of STAT3 (Lieschke
et al., 1994). The CCAAT/enhancer binding protein (C/EBP)
family is also critically involved in neutrophil differentiation. In
particular, C/EBPa is considered a master regulator of neutro-
phils because C/EBPa-deficient mice lack neutrophils (Zhang
et al., 1998). C/EBPε is involved in proper neutrophil differentia-
tion, because neutrophils from C/EBPε-deficient mice have
abnormal respiratory burst activity and lack secondary and
tertiary granules (Yamanaka et al., 1997). Recent reports have
also implicated the transcription factors Gfi-1 (Hock et al.,
2003) and Ikaros (Dumortier et al., 2003) in proper differentiation
of neutrophils. Overall, these findings suggest that neutrophil
differentiation is orchestrated by interplay among several tran-
scription factors.
Despite its importance in in vitro osteoclastogenesis and
several implications for its activity in myeloid lineage cells, the
roles of Jdp2 in vivo and its pleiotropic functions are completely
unknown. Here, we generated Jdp2–/– mice and discovered
critical roles of Jdp2 not only in bone homeostasis but also in
proper differentiation of neutrophils.
RESULTS
Jdp2–/– Mice Are Osteopetrotic because of Impaired
Osteoclastogenesis
First, we examined Jdp2 expression in mature myeloid cells,
such as macrophages, dendritic cells (DCs), neutrophils, and
osteoclasts. Jdp2 expression was substantially higher in these
cells than in lymphoid cells, such as T and B cells (Figure 1A).
Because Jdp2 expression was highest in osteoclasts (Figure 1A),
we focused on the regulation of Jdp2 expression in response to
RANKL. Jdp2 expression was significantly increased in M-CSF-
derived macrophages (MDMs) after RANKL stimulation (Figures
1B and 1C) but not after LPS stimulation (Figure S1 available
online). This transcriptional induction was dependent on c-Fos
(based on siRNA knockdown), which is recognized as a pivotal
transcription factor for osteoclastogenesis (Figure 1D). The
existence of this c-Fos-Jdp2 axis prompted us to explore the
role of Jdp2 in RANKL-induced osteoclastogenesis.
To evaluate osteoclastogenesis in vitro, Jdp2–/– mice were
generated (Figures S2A–S2C). Surprisingly, in vitro RANKL-
induced osteoclastogenesis and resorption pit formation wereImmcompletely abrogated in Jdp2–/– cells (Figure 2A). We also eval-
uated the characteristics of splenic macrophages and found
that the populations were similar between wild-type and
Jdp2–/– cells (Figures S2D, S2E, and S2G). In addition, Jdp2–/–
MDMs exhibited normal proliferation (Figure S2F) and RANK
and c-fms expression (Figure S2H).
As previously reported (Kawaida et al., 2003), induction of
osteoclast-associated genes, including TRAP and CTSK, was
abrogated in Jdp2–/– cells, whereas c-Fos induction was com-
parable between wild-type and Jdp2–/– cells (Figure 2B). We
also found that induction of NFATc1 mRNA and DNA binding
of NFATc1 to its promoter was partially suppressed in Jdp2–/–
cells in response to RANKL (Figures S2I and S2J). In addition,
Jdp2 had no effect on NFATc1 binding to its promoter region
(Figure S2K). Furthermore, DNA binding of NF-kB p65 was
normal (Figure S2L). The expression levels of Blimp1, a positive
regulator of osteoclastogenesis (Nishikawa et al., 2010), and
Blimp1 target genes, such as Irf8 and Bcl6, were comparable
(Figure S2M). RANKL-induced calcium oscillation was normal
in Jdp2–/– cells (Figure S2N). Because TREM2 is required for
osteoclast multinucleation (Humphrey et al., 2006), we examined
the TREM2 expression levels in wild-type and Jdp2–/–MDMs but
found no difference (Figure S2O). When TREM2 was stimulated
by antibody, wild-type MDMs formed increased numbers of
osteoclasts. In contrast, TREM2 stimulation had no effect on
osteoclastogenesis of Jdp2–/– MDMs (Figures S2P and S2Q).
Finally, retrovirus reconstitution of Jdp2 in Jdp2–/– MDMs
rescued RANKL-induced osteoclastogenesis (Figures S2R
and S2S). Together, these results indicate that the c-Fos-Jdp2
axis is critical for controlling osteoclastogenesis via proper
induction of NFATc1 and osteoclastogenic genes, such as
TRAP and CTSK.
These findings prompted us to explore the role of Jdp2 in
in vivo bone homeostasis. No apparent abnormalities were
observed in Jdp2–/– mice, although they did exhibit slightly
shortened femurs (Figure 2D). Radiographic analysis of the
femurs showed that Jdp2–/– mice had osteopetrosis accom-
panied by marked increases in trabecular bone volume and
number, compared with wild-type mice (Figures 2C, 2F, and
2G). These findings were further supported by increased bone
mineral density (BMD) in the full-length femurs of Jdp2–/– mice
(Figure 2E). Sections of proximal tibias from Jdp2–/– mice
also showed increased trabecular bone volume and number
(Figures 2H and 2I). Histomorphometric analysis revealedunity 37, 1024–1036, December 14, 2012 ª2012 Elsevier Inc. 1025
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Figure 2. Impaired Osteoclastogenesis in Jdp2–/– Mice
(A) MDMs from wild-type and Jdp2–/– mice were cultured with the indicated concentrations of RANKL. Representative TRAP staining and resorption pits
(arrowheads) are shown. Scale bar represents 200 mm.
(B) qPCR analysis of c-Fos, TRAP, and CTSK in wild-type and Jdp2–/– MDMs stimulated with 50 ng/ml RANKL (n = 3).
(C) Soft X-ray images of femurs.
(D) Femur lengths.
(E) BMDs of 20 longitudinal femur divisions.
(F) Representative mCT images of distal femurs (top, longitudinal view; middle, axial view of metaphyseal region; bottom, 3D view of metaphyseal region).
(G) Bone morphometric analysis of distal femurs by mCT.
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Roles of Jdp2 in Osteoclasts and Neutrophilsa significant reduction in the osteoclast surface/bone surface
ratio in Jdp2–/– mice, whereas the osteoblast surface/bone
surface ratio and bone formation rate were normal (Figures 2J
and 2K). Consistent with the decreased osteoclastogenesis
in vivo, the serum bone resorption marker TRACP5b was lower
in Jdp2–/– mice (Figure 2L). Furthermore, wild-type mice
engrafted with bone marrow cells from Jdp2–/– mice had an
increased bone volume phenotype (Figures S2T and S2U).
Collectively, these results indicate that Jdp2 is critical for
controlling osteoclastogenesis both in vitro and in vivo.
Neutrophils in Jdp2–/– Mice Are Morphologically Normal
but Show Impaired Ly6G Expression
A recent report suggested that Jdp2 may be involved in the
choice between lymphoid or myeloid differentiation (Ji et al.,
2010). Therefore, we focused on the populations of lymphoid
andmyeloid cells (Figure S3A). No differences in the expressions
of cell surface phenotype markers and numbers and ratios of
T cells, B cells, and DCs in the spleen were observed between
wild-type and Jdp2–/– mice (Figure S3A). We also checked the
cytokine production (Figures S3B and S3C), bactericidal func-
tion (Figure S3D), superoxide production (Figure S3E), and
phagocytosis activity (Figure S3F) in Jdp2–/– MDMs and conven-
tional DCs (cDCs), and all phenotypes were normal.
Because Jdp2 was highly expressed in mature splenic neutro-
phils (Figure 1A), we compared the Jdp2 mRNA and protein
expression between splenic and bone marrow neutrophils.
Jdp2 expression in bone marrow mature CD11b+Ly6Ghi neutro-
phils was lower than that in splenic mature CD11b+Ly6Ghi
neutrophils, but higher than that in bone marrow immature
CD11b+Ly6Glo neutrophils (Figures S3G and S3H). These find-
ings suggest that Jdp2 gradually increases during neutrophil
differentiation and maturation.
To check the maturity of neutrophils from Jdp2–/– mice, we
performed FACS analyses by using CD11b and Ly6G markers
(Figure 3A). In Jdp2–/– bone marrow cells, the proportion of the
CD11b+Ly6Ghi population was shifted toward the CD11b+
Ly6Glo population (Figure 3A). This low level of Ly6G indicated
accumulation of immature cells. However, contrary to our ex-
pectation, Jdp2–/– neutrophils displayed a normal segmented
nuclear morphology (Figure 3A). Because the CD11b+ population
includes a Ly6ChiLy6Glo inflammatory monocyte population
(Colonna et al., 2004; Lagasse and Weissman, 1996) and a
Ly6CloLy6G+ neutrophil population, CD11b+ cells were further
gated on CD11b+Ly6CloLy6G+ neutrophils and CD11b+Ly6Chi
Ly6Glo inflammatory monocytes to exclude monocytes from
the Jdp2–/– CD11b+Ly6G+ population (Figure 3B). Among
CD11b+Ly6CloLy6G+ neutrophil populations, the CD11b+Ly6Clo
Ly6Ghi population was shifted to the CD11b+Ly6CloLy6Glo
population in Jdp2–/– mice (Figure 3B). In contrast, CD11b+(H) Representative proximal tibias.
(I) Bone morphometric analysis of proximal tibias.
(J) TRAP staining of metaphyseal portions of tibias.
(K) Bone histomorphometric analysis of metaphyseal portions of tibias.
(L) Serum levels of TRACP5b and alkaline phosphatase (ALP).
Abbreviations: BV/TV, bone volume per tissue volume; Tb.Th, trabecular bone
Oc.S/BS, osteoclast surface per bone surface; ES/BS, eroded surface per bone
rate. Error bars, SE. *p < 0.05; **p < 0.01 (n = 4).
ImmLy6ChiLy6Glo inflammatory monocyte populations were compa-
rable between wild-type and Jdp2–/– cells (Figure 3B). We also
confirmed that both wild-type and Jdp2–/– CD11b+Ly6CloLy6G+
neutrophil populations had similar segmented nuclei (Figure 3B).
To further assess the abnormal bone marrow CD11b+
Ly6CloLy6G+ neutrophil population in Jdp2–/– mice, we analyzed
the cellular microstructure by transmission electron microscopy
(TEM) (Figure 3C). However, the intracellular morphology of
Jdp2–/– cells seemed normal (Figure 3C). To determine whether
the abnormal neutrophils accumulated only in the bone marrow,
we performed FACS analyses of thioglycollate-elicited perito-
neal neutrophils and splenocytes (Figures 3D and 3E). An atyp-
ical CD11b+Ly6CloLy6Glo population was observed in Jdp2–/–
peritoneal (Figure 3D) and splenic (Figure 3E) neutrophils. To
determine whether the defect in neutrophils in Jdp2–/– mice
was bone marrow derived and cell intrinsic, we engrafted irradi-
ated wild-typemice with Jdp2–/– or wild-type bonemarrow. After
reconstitution, we observed the same phenotype of neutrophils
in the wild-type mice with Jdp2–/– bone marrow as in the
Jdp2–/– mice (Figures S3O–S3Q). Together, these findings
suggest that Jdp2–/– neutrophils are morphologically normal
but have diminished Ly6G expression and that this abnormality
arises in a cell-intrinsic manner.
Impaired Apoptosis and Bactericidal Function
in Jdp2–/– Neutrophils
Intriguingly, we observed slight increases in CD11b+Ly6Clo
Ly6G+ neutrophil numbers (20%) in Jdp2–/– bone marrow and
peripheral populations (Figures 3A, 3B, and 3E). Given this
observation, we examined the spontaneous apoptosis of
Jdp2–/– peritoneal neutrophils (Figure 3F). To our surprise,
Jdp2–/– neutrophils showed impaired apoptosis compared with
wild-type neutrophils (Figure 3F). Microarray and quantitative
PCR (qPCR) analyses of neutrophils revealed that Bcl-2 expres-
sion was significantly increased in Jdp2–/– neutrophils, whereas
Jdp2 deficiency had no effect on the diverse array of other Bcl-2-
associated genes (Figures 3G–3I). Next, several assays were
used to examine Jdp2–/– peritoneal neutrophil function. First,
the capacity of Jdp2–/–mice to recruit neutrophils into the perito-
neal cavity after thioglycollate injection was determined, with no
difference in cell numbers found between wild-type and Jdp2–/–
mice (Figure S3I). Second, we checked the cytokine production
by Jdp2–/– neutrophils and found that Jdp2 deficiency did not
alter cytokine production in response to TLR ligands (Figure S3J).
Third, we analyzed the function of Jdp2 in NET formation. Intrigu-
ingly, we observed a 50% reduction in NET formation in neutro-
phils from Jdp2–/– mice in response to Staphylococcus aureus
andCandida albicans infection (Figures 3J–3M). Fourth, because
ROS, such as superoxide, are required for NET formation, we
quantified superoxide production by Jdp2–/– neutrophils inthickness; Tb.N, trabecular bone number; Tb.Sp, trabecular bone spacing;
surface; Ob.S/BS, osteoblast surface per bone surface; BFR, bone formation
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Figure 3. Abnormal Phenotype of Jdp2–/– Neutrophils
(A) FACS analysis of wild-type and Jdp2–/– bone marrow cells via Ly6G and CD11b markers. Gated cells were sorted and stained with May-Grunwald-Giemsa.
(B) CD11b+ populations in (A) were further analyzed with Ly6C marker. CD11b+Ly6CloLy6G+ neutrophils (N+/+ and N/) were sorted and stained as in (A).
(C) N+/+ and N/ cells were fixed, stained with diaminobenzidine, and analyzed by TEM. Scale bars represent 2 mm.
(D and E) Peritoneal neutrophils (D) and splenocytes (E) were analyzed as in (B).
(F) Peritoneal neutrophils were cultured in vitro and analyzed for the percentage of annexin V-positive cells by FACS (n = 3 independent experiments).
(G) mRNA levels of apoptosis-regulating genes in bone marrow CD11b+Ly6CloLy6G+ neutrophils (N+/+ and N/) analyzed by a microarray.
(H and I) Bcl2 mRNA (H) and protein (I) expression levels in wild-type and Jdp2–/– peritoneal neutrophils were analyzed by qPCR and protein immunoblotting,
respectively (n = 3).
(J) Peritoneal neutrophils were infected by S. aureus for 2 hr (MOI = 50) and stained by Hoechst and anti-histone H3 Cit3 Ab. DNA-histone H3 Cit3 Ab double-
positive structures were defined as NETs.
(K) 50 microscopic fields (403) in wells containing S. aureus-infected neutrophils, shown in (J), were checked and the rate of NET appearance was calculated
(n = 4 observations).
(L) Peritoneal neutrophils were infected by C. albicans for 2 hr (MOI = 50) and stained as in (J).
(M) C. albicans-induced NET formation in (L) was measured as in (K).
(N) Peritoneal neutrophils were stimulated with 100 mg/ml Zymosan for 15 min and supernatant superoxide levels were measured.
(O) S. aureus killing by peritoneal neutrophils. Phagocytosis was inhibited by cytochalasin D and bacterial killing was measured (Extra) (n = 6).
(P) C. albicans killing by peritoneal neutrophils was determined as in (O).
Error bars, SE. *p < 0.05.
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Roles of Jdp2 in Osteoclasts and Neutrophilsresponse to Zymosan and Curdlan. We observed 50% reduc-
tions in superoxide production in Jdp2–/– neutrophils (Figures
3N and S3L). We also checked the expression of Dectin-1, a
Curdlan receptor, and observed similar expression levels
between wild-type and Jdp2–/– neutrophils (Figure S3K). To
clarify the mechanisms of decreased superoxide production in
Jdp2 deficiency, we checked the expression levels of NADPH
oxidase subunits and found that NCF1 expression was lower in1028 Immunity 37, 1024–1036, December 14, 2012 ª2012 Elsevier InJdp2–/– neutrophils than in wild-type cells (Figure S3M). There-
fore, we infected Jdp2–/– neutrophils with a retrovirus encoding
NCF1 and measured the superoxide production. However, the
rescue of Jdp2–/– neutrophils by NCF1 was less efficient than
that by Jdp2 (Figure S3N). Thus, increased NCF1 can partially
rescue the impaired superoxide production in Jdp2–/– neutro-
phils. Finally, to determine whether the functional defects
of Jdp2–/– neutrophils were associated with bacterial killingc.
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Figure 4. G-CSF Response Kinetics of Jdp2–/– Cells
(A) G-CSFR mRNA levels in wild-type and Jdp2–/– bone marrow CD11b+Ly6CloLy6G+ neutrophils (N+/+ and N/) measured by qPCR. Error bars, SE (n = 3).
(B) Cells in (A) were stimulated with 100 ng/ml G-CSF. STAT3 and pY-STAT3 levels were detected by immunoblotting.
(C) mRNA levels of STAT3 target genes in CD11b+Ly6CloLy6G+ neutrophils (N+/+ and N/) analyzed by a microarray.
(D) G-CSF (1 mg) was subcutaneously injected into wild-type and Jdp2–/– mice from days 0 to 3. At 6 hr after the last injection, blood was collected and
CD11b+Ly6G+ neutrophils were counted. Error bars, SE (n = 3). *p < 0.05.
(E and F) Bone marrow cells were cultured for 7 days in MethoCult. Total numbers of CFU-G, CFU-M, and CFU-GM colonies (E) and their rates (F) were
determined. Error bars, SE (n = 6).
(G) Bone marrow cells were cultured for 7 days in MethoCult with 50 ng/ml G-CSF. Representative images of CFU-G and diaminobenzidine plus May-Grunwald-
Giemsa-stained individual cells are indicated.
(H) CFU-G in (G) were collected and analyzed by FACS with CD11b and Ly6G markers.
(I) Jdp2–/– bonemarrow cells were infectedwith a retrovirus encoding Jdp2 andGFP (lzr-Jdp2) or GFP alone (lzr-empty) with G-CSF for 9 days. CD11b+GFP+ cells
were gated and Ly6G expression levels were quantified by FACS. Gated cells were also sorted and stained by May-Grunwald-Giemsa (upper left insets in the
scatter plots).
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Roles of Jdp2 in Osteoclasts and Neutrophilsdeficits, we performed in vitro killing assays with S. aureus and
C. albicans (Figures 3O and 3P). Phagocytosis-dependent intra-
cellular killing was inhibited by pretreating neutrophils with cyto-
chalasin D. We observed that component killing mainly occurred
in the extracellular space (Figures 3O and 3P) and that whole and
extracellular bacterial killing by neutrophils from Jdp2–/– mice
was significantly decreased compared with wild-type mice
(Figures 3O and 3P). Together, these results clearly indicate
that the bactericidal function is impaired in Jdp2–/– neutrophils.
Abnormal Differentiation of Jdp2–/– Neutrophils In Vitro
Is Corrected by Re-expression of Jdp2
To investigate whether G-CSF signaling is altered by Jdp2 defi-
ciency, we examined the expression levels of G-CSF receptorImmand STAT3.We found that G-CSF receptor (G-CSFR) expression
was comparable between wild-type and Jdp2–/– neutrophils
(Figure 4A), as was the expression of both STAT3 and phosphor-
ylated STAT3 (Figure 4B). Microarray data confirmed the normal
expression levels of G-CSF target genes (Figure 4C). We also
counted the blood neutrophil numbers after intraperitoneal
G-CSF injection and found comparable increasing rates of
neutrophil numbers between wild-type and Jdp2–/– mice (Fig-
ure 4D). Thus, loss of Jdp2 does not influence G-CSF signaling.
Subsequently, we examined whether the altered differentia-
tion of neutrophils in Jdp2–/–mice was a late-phase abnormality.
Jdp2–/– bone marrow cells gave rise to the same numbers of
granulocyte colony-forming units (CFU-G), granulocyte-macro-
phage colony-forming units (CFU-GM), and macrophageunity 37, 1024–1036, December 14, 2012 ª2012 Elsevier Inc. 1029
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Roles of Jdp2 in Osteoclasts and Neutrophilscolony-forming units (CFU-M) as did wild-type cells, with similar
rates of formation (Figures 4E and 4F). We also added G-CSF to
stem cell medium and cultured bonemarrow cells (Figure 4G). As
expected, the colony numbers (data not shown) andmorphology
(Figure 4G) between the two cell types were similar, but Ly6G
expression was decreased in cells derived from Jdp2–/– bone
marrowcolonies (Figure 4H). Together, our findings imply that the
abnormality in neutrophils from Jdp2–/– mice arises in the late
differentiation phase and not in the initial differentiation phase.
Finally, we determined whether reintroduction of Jdp2 could
rescue the terminal differentiation. We infected Jdp2–/– bone
marrow cells with a retrovirus encoding Jdp2 and GFP or GFP
alone and cultured the cells in medium containing G-CSF (Fig-
ure 4I). After 9 days, the cells were harvested and their Ly6G
expression levels in gated GFP-positive neutrophils were
quantified by FACS (Figure 4I). As expected, Jdp2–/– bone
marrow-derived neutrophils infected with the Jdp2-GFP retro-
virus exhibited increased Ly6G expression compared with
control GFP-only cells (Figure 4I). Thus, the defect in neutrophil
differentiation in Jdp2–/– mice appears to be cell autonomous
and can be corrected by re-expression of Jdp2.
Primary Granule mRNA Expression Is Elevated
in Jdp2–/– Neutrophils
ThemRNA levels of granule genes are higher in immature neutro-
phils than in mature neutrophils (Martinelli et al., 2004). There-
fore, we analyzed the diverse RNAs of CD11b+Ly6CloLy6G+
bone marrow neutrophils encoding primary, secondary, and
tertiary granules by using microarray data (Figure 5A). Intrigu-
ingly, the mRNA levels for primary granule proteins, such as
MPO, CTSG, and PR3, were significantly increased in Jdp2–/–
neutrophils, whereas those for secondary and tertiary granule
proteins were comparable to control cells (Figure 5A). The
expression of other bactericidal granule proteins, such as Lipo-
calin2 and Cramp, was comparable (Figure S4A). We confirmed
these aberrant primary granule expressions in bone marrow and
peritoneal neutrophils by qPCR (Figures 5B and 5C). However,
in immunoblotting analyses, the expression levels of primary
granule proteins (Figure 5D) and their degranulation in response
to LPS (Figure S4B) seemed comparable between wild-type
and Jdp2–/– neutrophils.
To reveal the mechanism of the aberrant mRNA expression in
Jdp2–/–neutrophils,we selectedaset of geneswhoseexpression
levels were more abundant in Jdp2–/– neutrophils than in wild-
type cells (Figure S4C) based on microarray data and examined
their promoters for the presence of transcription factor binding
sites. The analysis revealed that C/EBP binding sequences
were highly enriched in the promoters of Jdp2-regulated genes
compared with randomly selected gene promoters (Figures
S4C–S4E). Further, we found that C/EBP binding sites
were most enriched among 198 transcription factor binding
sequences tested (Table S1). Thus, we quantified the mRNAs
of the C/EBP gene family involved in myeloid differentiation.
However, their expression levels were comparable (Figure 5E).
C/EBPa was reported to be the master regulator of the expres-
sion of primary granule genes (Zhang et al., 1998). Therefore, we
examined the DNA-binding activities of C/EBPa and C/EBPb
to their consensus oligonucleotides by using ELISA-based tran-
scription factor kits (Figure 5F). Although the protein expression1030 Immunity 37, 1024–1036, December 14, 2012 ª2012 Elsevier Inlevels were again comparable (Figure 5G), C/EBPa, but not
C/EBPb, DNA binding was increased in Jdp2–/– neutrophils
(Figure 5F). In addition, Jdp2 binding to the C/EBPa promoter
was not detected by chromatin immunoprecipitation (ChIP) anal-
yses (Figure 5H). When GFP-fused Jdp2 was retrovirally overex-
pressed in primary neutrophils, its expression was restricted to
the nucleus (Figure S4F). These observations led us to examine
the binding of Jdp2 to C/EBPa, and an association between
C/EBPa and Jdp2 was found by immunoprecipitation (Figures
5I and 5J). From this, we examined the effect of Jdp2 on the
transcriptional activity of C/EBPa (Figure 5K). For this experi-
ment, we used a luciferase reporter plasmid driven by C/EBP
transcriptional response elements. Overexpression of the
C/EBPa gene only activated this promoter, whereas simul-
taneous expression of Jdp2 dose dependently reduced the
activity of the promoter to the control level (Figure 5K). Together,
these findings suggest that Jdp2 inhibits the transcriptional
activity of C/EBPa by directly binding to the gene and inhibiting
C/EBPa from binding to its target sequence. We also over-
expressed C/EBPa in wild-type bone marrow cells and found
that C/EBPa enhanced primary granule mRNAs (Figures S4G
and S4H). Furthermore, when we re-expressed Jdp2 in Jdp2–/–
bone marrow cells, DNA binding of C/EBPa and expression of
primary granule genes were downregulated (Figures S4I and
S4J). We also overexpressed C/EBPa in wild-type differentiated
neutrophils (Figure S4K) and found that expression of Bcl-2
(Figure S4M) but not Ly6G (Figure S4L) was induced, leading to
impaired apoptosis (Figure S4N). Together, our observations
strengthen the idea that Jdp2–/– neutrophils are immature and
suggest that increased primary granule and Bcl-2mRNA expres-
sions are attributable to increased C/EBPa activation.
ATF3 Is a Target of Jdp2 andRegulates Ly6GExpression
Among AP-1 family members, ATF3 is the closest relative of
Jdp2 (Figure 6A). This information prompted us to measure
ATF3 expression in neutrophils. ATF3 expression in bone
marrow and peritoneal neutrophils was significantly increased
(Figure 6B). We also overexpressed Jdp2 in wild-type and
Jdp2–/– neutrophils and found that Jdp2 suppressed ATF3
expression (Figures 6C and 6D). Jdp2 is known to act as an
epigenetic regulator of gene expression (Jin et al., 2006).
Therefore, we analyzed the genome-wide status of histone
acetylation, H3K4 trimethylation, and H3K27 trimethylation in
wild-type and Jdp2–/– peritoneal neutrophils by using the
ChIP-sequencing (ChIP-Seq) technique (Figure 6E). First, genes
were chosen based on their differences in expression in
wild-type and Jdp2–/– neutrophils. However, we did not find an
apparent correlation between epigenetic statuses (data not
shown). Moreover, primary granule genes did not have sig-
nificant peaks for acetyl-histone, H3K4me3, and H3K27me3
in either wild-type or Jdp2–/– peritoneal neutrophils (Figure S5),
indicating that expression of these genes is not regulated
by the epigenetic status. When we focused on the ATF3
locus, we found a dramatic increase in the acetyl-histone sta-
tus of the promoter region close to the transcription start site (Fig-
ure 6E). However, the same region had comparable H3K4me3
and H3K27me3 statuses (Figure 6E). By ChIP analyses, we
confirmed an increase in the acetyl-histone status at the ATF3
promoter region in Jdp2–/– peritoneal neutrophils and observedc.
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Figure 5. Aberrant mRNA Levels of Primary
Granule Genes in Jdp2–/– Neutrophils
(A) Primary, secondary, and tertiary granule mRNA
levels in bone marrow CD11b+Ly6CloLy6G+
neutrophils (N+/+ and N/) analyzed by a mi-
croarray.
(B and C) MPO, CTSG, and PR3 mRNA levels in
CD11b+Ly6CloLy6G+ neutrophils (N+/+ andN/)
(B) and peritoneal neutrophils (C) measured by
qPCR.
(D) Primary granule protein levels in peritoneal
neutrophils from wild-type and Jdp2–/– mice.
(E) C/EBP gene family mRNA levels in peritoneal
neutrophils from wild-type and Jdp2–/– mice
measured by qPCR.
(F) DNA-binding activities of C/EBPa and C/EBPb
in wild-type and Jdp2–/– peritoneal neutrophils
measured with a TransAM Transcription Factor
Assay Kit.
(G) C/EBPa protein levels in nuclear extracts from
wild-type and Jdp2–/– peritoneal neutrophils
analyzed by immunoblotting.
(H) ChIP analyses with a Jdp2 Ab of lysates from
wild-type and Jdp2–/– peritoneal neutrophils. C/
EBPa and C/EBPb promoter regions were de-
tected by PCR.
(I) 293T cells were transfected with the indicated
pCMV expression vectors. After anti-Jdp2 immu-
noprecipitation (IP), input and immunoprecipitates
were analyzed by immunoblotting with C/EBPa
and Jdp2 Abs.
(J) Wild-type peritoneal neutrophils were lysed.
After anti-Jdp2 and control IgG IP, immunopre-
cipitates were analyzed by immunoblotting with
a C/EBPa Ab.
(K) Luciferase assays examining the effects of
Jdp2 on the transcriptional activity of C/EBPa.
Error bars, SE (n = 3). *p < 0.05.
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Furthermore, we found that Jdp2 overexpression in wild-type
neutrophils suppressed ATF3 promoter acetylation (Figure 6G).Immunity 37, 1024–1036, DeFinally, to determine whether increased
ATF3 expression affected neutrophil
differentiation, we infected wild-type
bone marrow cells with a retrovirus en-
coding ATF3 and GFP or GFP alone and
analyzed the cells by FACS after 5 days
as described earlier. Intriguingly, neutro-
phils infected with the ATF3-GFP retro-
virus showed decreased Ly6G expres-
sion levels but unchanged cellular
morphology, compared with GFP-alone
control cells (Figure 6H). Thus, ATF3 is
a negative regulator of neutrophil differ-
entiation, and its expression is strictly
regulated by Jdp2.
Jdp2–/– Mice Are Highly Susceptible
to Bacterial and Fungal Infection
Because decreased neutrophil function is
an important risk factor for C. albicansinfection, we checked the susceptibility of Jdp2–/– mice to
C. albicans challenge (Figures 7A–7C). We observed a slight
but significant increase in C. albicans susceptibility in Jdp2–/–cember 14, 2012 ª2012 Elsevier Inc. 1031
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Figure 6. ATF3 Is a Target of Jdp2 and Modulates Ly6G Surface Expression
(A) Phylogenetic tree for AP-1 family proteins and Jdp2.
(B) ATF3 mRNA levels in bone marrow CD11b+Ly6CloLy6G+ neutrophils (N+/+ and N/) analyzed by qPCR.
(C and D)Wild-type (C) and Jdp2–/– (D) bonemarrow cells were infected with a retrovirus encoding Jdp2 and GFP (lzr-Jdp2) or GFP alone (lzr-empty) and cultured
with G-CSF. After 5 days, the cells were harvested and CD11b+GFP+ cells were sorted. ATF3 mRNA levels were measured by qPCR.
(E) ChIP-seq enrichment profiles for acetyl-histone, H3K4me3, and H3K27me3 at the ATF3 locus in wild-type and Jdp2–/– peritoneal neutrophils.
(F) ChIP analyses with Jdp2 and acetyl-histone Abs of lysates from wild-type and Jdp2–/– bone marrow CD11b+Ly6CloLy6G+ neutrophils (N+/+ and N/). DNA
fragments of the ATF3 promoter region were detected by PCR.
(G) ChIP analyses with an acetyl-histone Ab of lysates in (C). DNA fragments of the ATF3 promoter region were detected by PCR.
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Figure 7. Jdp2–/– Mice Are Susceptible to Infection
(A–C)C. albicanswas intravenously injected into Jdp2+/+Jdp2+/– mice (control, n = 8) and Jdp2–/– mice (/, n = 8) and themice were monitored (A). Jdp2–/– mice
showed significantly worse survival than control mice (p < 0.05). CFU in the indicated organs (B) and serum cytokine levels (C) were determined at 36 hr after
infection.
(D–F) S. aureus was intravenously injected into Jdp2+/+Jdp2+/– mice (control, n = 6) and Jdp2–/– mice (/, n = 6) and the mice were monitored (D). Jdp2–/– mice
showed significantly worse survival than control mice (p < 0.05). CFU in the indicated organs (E) and serum cytokine levels (F) were determined at 36 hr after
infection.
(G) S. aureus was intravenously injected into wild-type mice reconstituted by transplantation of wild-type (+/+ > +/+, n = 7) or Jdp2–/– (/ > +/+, n = 7) bone
marrow and the mice were monitored. The survival was significantly worse in / > +/+ mice than in +/+ > +/+ mice (p < 0.05).
Error bars, SE (n = 4 unless indicated). *p < 0.05.
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CFU in their liver compared with wild-type mice (Figure 7B). The
serum IL-12 levels were significantly elevated in Jdp2–/– mice,
compared with wild-type mice, but the serum TNF-a and IL-6
levels were comparable (Figure 7C). We also infected Jdp2–/–
and wild-type mice with S. aureus (Figures 7D–7F). Surprisingly,
Jdp2–/– mice were highly susceptible to S. aureus infection,
compared with wild-type mice (Figure 7D). Jdp2–/–mice showed
significantly elevated numbers of S. aureus CFU in their blood
and kidneys, compared with wild-type mice (Figure 7E). In
contrast, the serum cytokine levels were not significantly altered
(Figure 7F). To evaluate the relevance of hematopoietic Jdp2
deficiency to protective immunity against pathogens, we irradi-
ated wild-type mice and reconstituted them with bone marrow
from wild-type or Jdp2–/– mice (Figure 7G). Chimeric mice lack-
ing Jdp2 in their hematopoietic system showed significantly
increased susceptibility to S. aureus (Figure 7G). To evaluate
the importance of lymphocytes in protective immunity against
S. aureus infection in our experimental model, we depleted T(H) Wild-type bone marrow cells were infected with a retrovirus encoding ATF3
5 days, CD11b+GFP+ cells were gated and Ly6G expression levels were quantified
(upper left insets in the scatter plots).
Error bars, SE (n = 3). *p < 0.05.
Immand B cells in wild-type mice reconstituted with bone marrow
from wild-type mice by using CD3 and CD20 Abs (Figure S6A).
However, this depletion had no effect on survival in response
to S. aureus (Figure S6B). Thus, we think our infection model
reflects the function of cells other than T and B cells. Next, we
depleted neutrophils in bone marrow chimeric mice by using
a Ly6G Ab (Figure S6C). We infected the neutrophil-depleted
chimeric mice with S. aureus and observed no significant differ-
ence in S. aureus-induced lethality between wild-type and
Jdp2–/– chimeric mice (Figure S6D). Thus, these findings suggest
that the increased susceptibility to S. aureus in Jdp2–/– mice is
due to an abnormal neutrophil phenotype.
DISCUSSION
We have demonstrated that Jdp2 plays a critical role in
osteoclastogenesis in vivo. We also discovered that in vitro
osteoclastogenesis was completely abolished in Jdp2–/– cells.
Furthermore, RANKL-mediated Jdp2 induction appeared to beand GFP (lzr-ATF3) or GFP alone (lzr-empty) and cultured with G-CSF. After
by FACS. Gated cells were also sorted and stained byMay-Grunwald-Giemsa
unity 37, 1024–1036, December 14, 2012 ª2012 Elsevier Inc. 1033
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pressed, meaning that Jdp2 may also positively regulate its
activity. However, we did not detect a direct association
between Jdp2 and NFATc1 (data not shown), and Jdp2 had no
effect on NFATc1 binding to its promoter region. Thus, indirect
mechanisms are likely to modulate the NFATc1 activity.
The defect in osteoclastogenesis in Jdp2–/– mice in vivo was
relatively mild compared with its effect on in vitro osteoclasto-
genesis. It has been reported that calcium signaling is important
for NFATc1 activation and that such costimulatory signaling is
supported by ITAM-harboring adaptors, such as FcRg and
DNAX-activation protein 12 (DAP12) (Koga et al., 2004). Because
RANKL-induced calcium oscillation was normal in Jdp2–/– cells
in this study, signaling through ITAM-harboring molecules is
likely to be normal. These findings further suggest that another
unknown costimulatory signaling pathway may be compen-
sating for the Jdp2 deficiency in vivo. Further studies are needed
to explore the role of Jdp2 in osteoclasts, but our data provide
insights into c-Fos-Jdp2 axis-mediated osteoclastogenesis
and suggest a basis for the possibility of Jdp2-targeted thera-
peutic approaches to treat osteoporosis.
Our present data clearly revealed an unexpected and strict
requirement for Jdp2 in proper differentiation of neutrophils.
Jdp2–/– neutrophils were morphologically normal but had
impaired surface expressionof Ly6G, apoptosis, andbactericidal
function. Furthermore, C/EBPa activation and expression of Bcl-
2 and primary granule genes were increased. Our data also
suggest that Jdp2 suppresses C/EBPa by directly binding to it.
Notably, Jdp2–/– neutrophils showed normal primary granule
protein levels but increased mRNA levels. Similar discrepancies
have been reported in several knockout mice. For example,
Gfi1-deficient neutrophils exhibit immature morphology and
significant increases in mRNAs, such as primary granule genes
and C/EBPa, but lack granules (Hock et al., 2003). Meanwhile,
Ikaros-deficient neutrophils have impaired Ly6G levels but
normal granule and nuclear morphology, whereas secondary
granule mRNAs seem to be increased (Dumortier et al., 2003).
Thus, increased mRNA levels of granule genes can be consid-
ered a leading indicator for obstruction of differentiation. Unfortu-
nately, we cannot explain why the granule mRNA and protein
levels are dissociated in neutrophils. One hypothetical explana-
tion is that there are insufficient amounts of translational compo-
nents for granule synthesis in Jdp2–/– neutrophils.
Jdp2 is homologous to ATF3, a negative regulator of TLR
signaling, and ATF3 expression is suppressed by Jdp2 in fibro-
blasts (Weidenfeld-Baranboim et al., 2009). Our genome-wide
analysis revealed that the ATF3 promoter region was highly acet-
ylated in Jdp2–/– neutrophils. Furthermore, we discovered that
Jdp2 directly binds to the ATF3 promoter in neutrophils. Impor-
tantly, ATF3 may function as a novel negative regulator of Ly6G.
We also revealed that Jdp2–/– mice are highly susceptible to
infection. The impaired NET formation and ROS production in
Jdp2–/– neutrophils may be responsible for the increased
susceptibility to infection in Jdp2–/–mice. Intriguingly, this defect
in the in vitro bactericidal function of Jdp2–/– neutrophils was
mild compared with the highly impaired resistance to S. aureus
infection. We cannot completely exclude the possibility of
defects in other immune cells. Thus, our data suggest the impor-
tance of Jdp2 in host defense and also enhance curiosity to1034 Immunity 37, 1024–1036, December 14, 2012 ª2012 Elsevier Inclarify the importance of Jdp2 in a wide range of hematopoietic
cell functions.
Taken together, we have identified Jdp2 as a critical ‘‘osteo-
innate-immunological’’ regulator both in vivo and in vitro. Thus,
Jdp2-mediated gene regulation may be a critical target for the
development of therapeutics to control abnormal neutrophil-
and osteoclast-associated diseases.
EXPERIMENTAL PROCEDURES
Mice, Cells, and Reagents
The generation of Jdp2–/–mice is described in the Supplemental Experimental
Procedures. Mice were housed in specific-pathogen-free conditions and
all animal experiments were carried out with the approval of the
animal research committee of the Research Institute for Microbial Diseases
(Osaka University). Peritoneal neutrophils were prepared as described
(Bertram et al., 2012). B and T cells were isolated from splenocytes with
anti-B220 and anti-Thy-1.2 magnetic beads (Miltenyi Biotec), respectively.
Splenic dendritic cells (DCs) were isolated with anti-CD11c magnetic
beads (Miltenyi Biotec). Primary osteoclasts are prepared as described (Take-
gahara et al., 2006). Splenic- or bone marrow-derived CD11b+F4/80+ macro-
phages and CD11b+Ly6CloLy6G+ neutrophils were sorted with a FACSAria
(BD Biosciences). Conventional dendritic cells (cDCs) were prepared as
described (Kato et al., 2005). S. aureus 834 was kindly provided by A. Nakane
(Hirosaki University, School of Medicine, Aomori, Japan). This strain was
cultured on tryptic soy broth agar plates at 37C for 24 hr before use.
C. albicans THK519was obtained from a patient admitted to TohokuUniversity
Hospital (Sendai, Japan). These cells were cultured on potato dextrose agar
(PDA) plates (Eiken) at 30C for 72 hr before use. The pathogen-associated
molecular patterns (PAMPs), Abs, and ELISA kits listed in the Supplemental
Experimental Procedures were purchased. Phagocytosis was quantified
with a phagocytosis assay kit (500290; Cayman Chemical Company).
Superoxide and apoptosis levels were measured with a Diogenes Cellular
Luminescence Enhancement System (National Diagnostics) and annexin
V-indocarbocyanine (BioVision), respectively.
Analysis of Osteoclastogenesis and Bone Phenotype
For in vitro osteoclast culture, MDMswere generated as described (Maruyama
et al., 2006). MDMs were induced to differentiate into osteoclasts in the
presence of 25 ng/ml M-CSF and various concentrations of RANKL (R&D
Systems). After 3 days, TRAP staining was performed as described (Zhao
et al., 2006). For pit assays, MDMs were cultured on bone resorption assay
plates (Iwai Chemical Company) with 50 ng/ml RANKL. After 5 days, the plates
were immersed in 1 M NH4OH for 3 hr, and the resorption pits were counted.
The in vivo bone phenotype was analyzed as described in the Supplemental
Experimental Procedures.
Bone Marrow Transfer
Bone marrow transplantation was performed as described in the Supple-
mental Experimental Procedures.
qPCR
RNA was extracted from cells with TRIzol (Invitrogen Life Science Technolo-
gies), and reverse transcription was performed with ReverTra Ace (Toyobo
Co. Ltd.). qPCR was performed in an ABI PRISM 7500 with TaqMan Assay-
on-demand primers (Applied Biosystems).
Viral Gene Transfer and RNA Interference
Retroviral or lentiviral gene transfer was performed as described in the
Supplemental Experimental Procedures. A siRNA for c-Fos (Stealth RNAi
siRNA, MSS247212; Invitrogen) and a control oligo (Stealth RNAi siRNA,
negative control Med GC; Invitrogen) were introduced into MDMs with Lipo-
fectamine 2000 (Invitrogen) according to the manufacturer’s protocols.
Immunoblotting and Immunoprecipitation
Immunoblotting and immunoprecipitation were performed as described
(Kawagoe et al., 2009).c.
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A C/EBP reporter kit (CCS-001L; QIAGEN) and NFAT reporter kit (CCS-015L;
QIAGEN) were used for transient transfection into HEK293 cells with Lipofect-
amine 2000. Luciferase activities were measured with a Dual-Luciferase
Reporter Assay System (Promega), as described (Iwasaki et al., 2011).
Intracellular Calcium Imaging
MDMs were plated on poly-L-lysine-coated glass-bottom dishes and loaded
with 5 mM Fura-2/AM for 30 min in loading solution (115 mM NaCl, 5.4 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM HEPES, 10 mM glucose [pH 7.42]).
Fura-2 fluorescent images were analyzed as described (Kuroda et al., 2008).
Immunostaining, FACS, and TEM
Immunostaining of in vitro cultured peritoneal neutrophils was performed
essentially as described (Li et al., 2010). Peritoneal neutrophils were stimulated
by S. aureus or C. albicans for 2 hr (MOI = 50) and stained with Hoechst and
anti-histone H3 Cit3 Ab (Abcam). Abs for FACS were purchased from BD
Biosciences and used for cell staining. Data were acquired in a FACSCalibur
(BD Biosciences) and analyzed with FlowJo (Ashland). TEM was performed
as described in the Supplemental Experimental Procedures.
Colony Assay
Bone marrow cells were cultured with MethoCult (GFM3434; Stem Cell
Technologies) with or without G-CSF (50 ng/ml) supplementation, according
to the manufacturer’s protocol. After 7 days, the numbers of CFU-G, CFU-
M, and CFU-GM were counted.
Microarray, ChIP, and ChIP-seq Analyses
The microarray, ChIP, and ChIP-seq protocols and data analyses are
described in the Supplemental Experimental Procedures.
In Vitro and In Vivo Infection
In vitro bacterial killing assays were performed as described in the Supple-
mental Experimental Procedures. For in vivo infection, S. aureus was cultured
in tryptic soy broth for 15 hr at 37C. Cells were collected and suspended in
PBS. Mice were infected intravenously with 0.2 ml of solution containing 3 3
107S. aureus cells.C. albicanswere collected fromPDA plates and suspended
in PBS. Mice were infected intravenously with 0.2 ml of solution containing
2.5 3 105 C. albicans cells. The numbers of viable bacteria in various organs
were determined as described (Maruyama et al., 2007).
Statistical Analysis
Student’s t test was used to evaluate the significance of differences, with
significance set at p < 0.05. For survival curves, two groups were compared
with a log-rank test.
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